ISSN: 2329-6631
+44 1478 350008
Hari S Sharma
Healthcare transformations and disruptions in the biopharma industry: The future of biosimilars
Reenita Das
Noradrenergic control of neuroinflammation and cognitive function in Alzheimers disease
Mehrdad Shamloo
The end of biosimilars phase 3 clinical trials?
Francois-Xavier Frapaise